Biomarker-driven access to crizotinib in ALK-, MET-, or ROS1-positive malignancies in adults and children: Feasibility of the French National Acsé Program

  • Auteurs / Authors: Gilles Vassal , Natalie Hoog Labouret , Marie-Cécile Le Deley , Marta Jimenez , Frederique Nowak , Denis Moro-SibilotYann Godbert , Luc Taillandier , Jean-Yves Blay , Herve R. Bonnefoi , David Malka , Roch Houot , Thomas Aparicio , Bernard J. Escudier , Christophe Tournigand , Isabelle Ray Coquard , Pierre Laurent-Puig , Frederique Madeleine Penault-Llorca , Fabien M. Calvo , Agnes Buzyn
  • Journal / Conference: ASCO
  • Année / Year: 2014
  • PMID: Poster
  • Lien vers la publication: https://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.tps2647